Cardiology - Cardiology Xagena

CardiologyOnline

News

Drugs

Xagena Medicine

Xagena.net

Antiarrhythmic drugs: Dronedarone associated with increased risk of serious cardiovascular events or death

Patients with dyssynchronous yet viable ventricles are most likely to benefit from cardiac resynchronization therapy combined with defibrillation

Mild heart failure: Inspra reduces atrial fibrillation

PRODIGY study: appropriate duration of dual antiplatelet therapy after coronary stenting

2011 - Triple antiplatelet therapy in acute coronary syndromes

Pine-bark extract does not improve cardiovascular risk factors

Direct factor Xa inhibitors: Edoxaban compared with Enoxaparin sodium in preventing venous thromboembolism after total hip replacement

The association between heart disease and depression is more likely to cause death

Rivaroxaban has shown non-inferiority compared to Enoxaparin in patients with acute symptomatic deep vein thrombosis

Risk of dangerous drug interactions in heart patients using herbal supplements

2010 - Diet and physical activity may improve quality of life among adults at moderate to high risk for heart disease

Acetylsalicylic acid: primary prevention of vascular events in patients with asymptomatic disease cannot be supported

Future cardiovascular problems for patients with type D personality

Resistant hypertension: Darusentan decreases blood pressure

Atrial fibrillation: new predictive tool could be used to identify people at risk

Atrial fibrillation: ablation o antiarrhythmic drugs

Acetylsalicylic acid plus Clopidogrel reduces myocardial infarction risk in patients with acute coronary syndrome

FAMOUS trial: Pepcid prevents stomach and upper-intestinal ulcers in patients taking low-dose Acetylsalicylic acid

Antiplatelet agents: Brilinta first to show reduction in cardiovascular death in patients with acute coronary syndromes

Increased risk of hospital admission for bleeding in patients with myocardial infarction given more antithrombotic drugs

Efient may reduce stent thrombosis in patients with coronary stents

Actos may slow atherosclerosis

Lescol XL improves cardiac outcome after major vascular surgery

Pioglitazone may help slow atherosclerosis

Antidiabetic drugs: meta-analysis examines cardiovascular effects

Coronary stents: Prasugrel may reduce ischaemic outcomes, including stent thrombosis

Patients with acute coronary syndrome at risk of adverse events within 3 months after stopping Clopidogrel treatment

Coronary artery bypass graft surgery: MC-1 does not appear to reduce risk of myocardial infarction or death

Crestor can reduce plaques that cause myocardial infarction

Statins may also modestly reduce blood pressure

Next Pages [1] 2 3 4 5 6 7 8 9 10 »

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Pulmonology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions